Basit öğe kaydını göster

dc.contributor.authorAydin, F
dc.contributor.authorCokluk, C
dc.contributor.authorSenturk, N
dc.contributor.authorAydin, K
dc.contributor.authorCanturk, MT
dc.contributor.authorTuranli, AY
dc.date.accessioned2020-06-21T15:28:51Z
dc.date.available2020-06-21T15:28:51Z
dc.date.issued2006
dc.identifier.issn0926-9959
dc.identifier.issn1468-3083
dc.identifier.urihttps://doi.org/10.1111/j.1468-3083.2006.01510.x
dc.identifier.urihttps://hdl.handle.net/20.500.12712/20638
dc.descriptionWOS: 000237063100016en_US
dc.descriptionPubMed: 16684289en_US
dc.description.abstractStevens-Johnson syndrome (SJS) is a severe cutaneous eruption that most often appears as an adverse reaction to medication. In this report, we present two patients diagnosed with SJS, which developed in patients with brain tumour, after receiving cranial irradiation and phenytoin. Concomitant application of these two therapies may play an important role in the occurrence of the disease.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/j.1468-3083.2006.01510.xen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcranial irradiationen_US
dc.subjectcutaneous eruptionsen_US
dc.subjectEMPACTen_US
dc.subjectphenytoinen_US
dc.subjectStevens-Johnson syndromeen_US
dc.titleStevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoinen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume20en_US
dc.identifier.issue5en_US
dc.identifier.startpage588en_US
dc.identifier.endpage590en_US
dc.relation.journalJournal of the European Academy of Dermatology and Venereologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster